Presenters
Professor, Department of Medicine
Prof. John Eikelboom, MD, MBBS, MSc, FRCPC
Course Details
Direct oral anticoagulants (DOAC) are being used in replacement of warfarin to prevent stroke in patients with atrial fibrillation across a wide range of patient profiles. In this video, Professor John Eikelboom (Canada) shares insights on optimizing DOAC therapy in clinically important subsets of patients, such as Asians and those with comorbidities.
Estimated time of Completion: 28 mins.
PC-PH-105362 / October 2023